Hao Tang
About
In The Last Decade
Hao Tang
94 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 150
- Molecular Biology 1.8k
- Cancer Research 864
- Immunology 283
- Oncology 250
- Surgery 203
Countries citing papers authored by Hao Tang
This map shows the geographic impact of Hao Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Tang more than expected).
Fields of papers citing papers by Hao Tang
This network shows the impact of papers produced by Hao Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Tang. The network helps show where Hao Tang may publish in the future.
Co-authorship network of co-authors of Hao Tang
This figure shows the co-authorship network connecting the top 25 collaborators of Hao Tang. A scholar is included among the top collaborators of Hao Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Tang. Hao Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 5 | |
| 4 | 7 | |
| 5 | 6 | |
| 6 | 6 | |
| 7 | 4 | |
| 8 | 2 | |
| 9 | 11 | |
| 10 | 11 | |
| 11 | 4 | |
| 12 | 19 | |
| 13 | 14 | |
| 14 | 18 | |
| 15 | 212 | |
| 16 | 0 | |
| 17 | 8 | |
| 18 | Preparation and Characterization of PLGA Nanospheres Surface Modified with Biotinylated Chitosan | 1 |
| 19 | Anti-proliferative activity of the mTOR inhibitor AP23573 in combination with cytotoxic and targeted agents | 18 |
| 20 | Structure-based design of AP23573, a phosphorus-containing analog of rapamycin for anti-tumor therapy. | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.